- Home
- NMTC
NMTC
NeuroOne Medical Technologies Corporation
as 03-31-2025 4:00pm EST
| Founded: | 2009 | Country: | United States |
| Employees: | N/A | City: | EDEN PRAIRIE |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 129.9K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.25 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.55 - $1.39 | Next Earning Date: | 05-13-2025 |
| Revenue: | $5,749,521 | Revenue Growth: | 104.21% |
| Revenue Growth (this year): | 292.88% | Revenue Growth (next year): | N/A |
Latest NeuroOne Medical Technologies Corporation News
NMTC Breaking Stock News: Dive into NMTC Ticker-Specific Updates for Smart Investing
GlobeNewswire
13 days ago
NeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today’s Marketplace - Update
GlobeNewswire
13 days ago
NeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today’s Marketplace
GlobeNewswire
13 days ago
NeuroOne CEO Joins Today’s Marketplace To Discuss The Latest Treatments for Epilepsy
GlobeNewswire
20 days ago
NeuroOne® Accelerates Timeline of 510(k) Submission to FDA for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain
GlobeNewswire
a month ago
NeuroOne® to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
GlobeNewswire
2 months ago
NeuroOne® Reports First Quarter Fiscal Year 2025 Financial Results and Provides Corporate Update
GlobeNewswire
2 months ago
NeuroOne® to Report First Quarter Fiscal Year 2025 Financial Results on Wednesday, February 12 at 8:30 a.m. Eastern Time
GlobeNewswire
2 months ago
NeuroOne® Regains Compliance with Nasdaq Listing Requirements
Compare NMTC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "NMTC NeuroOne Medical Technologies Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.